NCT00029211

Brief Summary

This is a randomized trial to determine if echinacea is effective in shortening the length and/or lessening the severity of colds in children 2 through 11 years old.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Apr 2000

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2000

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

January 9, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 10, 2002

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2003

Completed
Last Updated

August 18, 2006

Status Verified

August 1, 2006

First QC Date

January 9, 2002

Last Update Submit

August 17, 2006

Conditions

Common Cold

Interventions

EchinaceaDRUG

Eligibility Criteria

Age2 Years - 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Parent available to observe child during the night
  • Parent peaks and reads English

You may not qualify if:

  • History of asthma or allergic rhinitis
  • History of auto-immune disease
  • History of chronic lung disease
  • Allergy to sunflower species

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Child Health Institute, University of Washington

Seattle, Washington, 98103, United States

Location

MeSH Terms

Conditions

Common Cold

Interventions

Echinacea extract

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPicornaviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Study Officials

  • James Taylor, MD

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH

Study Record Dates

First Submitted

January 9, 2002

First Posted

January 10, 2002

Study Start

April 1, 2000

Study Completion

March 1, 2003

Last Updated

August 18, 2006

Record last verified: 2006-08

Locations

US(1)